NCT07399379Completed
Augmented Reality as Discharge Information for Hospitalized Cardiology Patients
Implementation of an Augmented Reality System to Complement Discharge Information in Hospitalized Cardiology Patients
Source: ClinicalTrials.gov · Last updated 10 Feb 2026
Brief summary (registry, in English)
The goal of this clinical trial is to find out whether a simple augmented reality tool provided at hospital discharge can improve patients' understanding of their care, adherence to treatment, and health outcomes, compared with the usual discharge information. This study includes adult patients who are admitted to a cardiology department because of: * Ischaemic heart disease * Atrial fibrillation * Heart failure * Or who need a pacemaker implantation The main questions this study aims to answer are: * Does providing augmented reality information at discharge improve patients' perceived quality of care? * Does it improve patients' adherence to their prescribed treatment? * Does it reduce major cardiovascular events such as hospital readmission, heart attack, stroke, or cardiovascular death? Researchers will compare two groups of participants: * A control group, who will receive the usual medical discharge report. * An intervention group, who will receive the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application. Participants will: * Receive their discharge information according to the group they are assigned to. * Use the augmented reality application if they are in the intervention group. * Be followed over time to assess treatment adherence, patient experience, and cardiovascular events. This is a low-intervention, randomized, single-centre clinical trial conducted in Getafe, Madrid, Spain. Participation in this study does not involve taking any additional medication.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 303 (actual)
- First submitted
- 13 Jan 2026
- Start date
- 23 Feb 2024
- Primary completion date
- 16 Dec 2025
- Lead sponsor
- Hospital Universitario Getafe
- NCT number
- NCT07399379
What you commit to
- Study type: Interventional
- Participants enrolled: 303
- From 23 Feb 2024 to the primary completion date, 16 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No access to a mobile device.
- Untreated visual or hearing impairments that prevent viewing or understanding the videos.
- Inability to understand Spanish
Who the study is looking for
- Participants must have access to a mobile device (such as a smartphone or tablet).
- Participants must have been admitted to the Cardiology Department of Getafe University Hospital for ischemic heart disease, heart failure, atrial fibrillation, or pacemaker implantation.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario de Getafe Coordinator of this site? Confirm its status | Getafe | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.